TV News LIES

Monday, Jul 28th

Last update12:22:36 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Exposing Monsanto: Herbicide Linked to Birth Defects - the Vitamin A Connection

MonsantoMonsanto's herbicide Roundup, with glyphosate as the primary ingredient, has recently been linked to a fatal...

HIV/AIDS has migrated to Deep South, where stigma endures

HIV in AlabamaDr. Laurie Dill pointed to a large map in the hallway of Medical AIDS Outreach of...

Ebola now taking toll on doctors and other health care workers

Ebola kills doctorAn Ebola outbreak that has killed more than 670 people in Africa is now taking a...

Fed Court: Florida: doctors cannot discuss gun safety with patients

doctors cannot discuss gun safetyA federal appeals court is upholding a Florida law restricting what doctors can discuss about guns...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!